Inhibitors of dihydrofolate reductase as antitumor agents: design, synthesis and biological evaluation of a series of novel nonclassical 6-substituted pyrido[3,2-d]pyrimidines with a three- to five-carbon bridge

2018 ◽  
Vol 26 (9) ◽  
pp. 2674-2685 ◽  
Author(s):  
Hao Li ◽  
Fang Fang ◽  
Yunqi Liu ◽  
Liangmin Xue ◽  
Meng Wang ◽  
...  
ChemInform ◽  
2010 ◽  
Vol 31 (29) ◽  
pp. no-no
Author(s):  
Yi Xia ◽  
Zheng-Yu Yang ◽  
Peng Xia ◽  
Kenneth F. Bastow ◽  
Yuka Nakanishi ◽  
...  

MedChemComm ◽  
2015 ◽  
Vol 6 (5) ◽  
pp. 867-870 ◽  
Author(s):  
Xiangkai Kong ◽  
Zeyu Yao ◽  
Zuopeng He ◽  
Wenfang Xu ◽  
Jianwen Yao

Thiourea and nicotinamide-containing sorafenib analogs with better antiproliferative and anti-angiogenic activities than sorafenib were well designed and synthesized.


2020 ◽  
Vol 57 (6) ◽  
pp. 2548-2560
Author(s):  
Wen Li ◽  
Ya‐Yun Qi ◽  
Yuan‐Yuan Wang ◽  
Yi‐Yuan Gan ◽  
Li‐Hui Shao ◽  
...  

MedChemComm ◽  
2019 ◽  
Vol 10 (4) ◽  
pp. 573-583 ◽  
Author(s):  
Runde Xiong ◽  
Dongxiu He ◽  
Xiangping Deng ◽  
Juan Liu ◽  
Xiaoyong Lei ◽  
...  

According to the combination principle, target compounds were designed, and compound E20 might be a promising anti-tumor agent targeting gastric cancer.


Sign in / Sign up

Export Citation Format

Share Document